Sionna Therapeutics Inc. (Nasdaq: SION), a clinical-stage biopharmaceutical company on a mission to revolutionize the current ...
BofA Securities, Goldman Sachs & Co. LLC, Evercore ISI, Guggenheim Securities and Cantor acted as joint bookrunners for the offering.
Warner Bros. Discovery is undervalued, but CEO David Zaslav's debt reduction efforts show a promising future. Click here to ...
Titan America SA (“Titan America”), a subsidiary of Titan Cement International SA and parent company of its U.S. operations, ...
But when it comes to fixing Goldman’s woman problem, the firm has not shown the same urgency. When Solomon became CEO, he ...
U.S. consumers' 12-month inflation expectations jumped to 4.3% in February, the highest level since November 2023, according ...
Titan America has raised $384 million after pricing its U.S. initial public offering at $16 per share, within its targeted range, the cement producer said on Thursday.
Frontera's Guyana dispute and infrastructure review weigh on its future. Find out why low bond prices raise concerns for ...
Sionna Therapeutics Inc. (Nasdaq: SION), a clinical-stage biopharmaceutical company on a mission to revolutionize the current treatment paradigm for cystic fibrosis ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results